Production (Stage)
Zimmer Biomet Holdings, Inc.
ZBH
$92.64
$0.971.06%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.91B | 2.02B | 1.82B | 1.94B | 1.89B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.91B | 2.02B | 1.82B | 1.94B | 1.89B |
| Cost of Revenue | 549.80M | 583.80M | 530.90M | 553.30M | 512.30M |
| Gross Profit | 1.36B | 1.44B | 1.29B | 1.39B | 1.38B |
| SG&A Expenses | 756.90M | 703.00M | 705.20M | 733.20M | 734.40M |
| Depreciation & Amortization | 151.00M | 157.60M | 148.20M | 144.00M | 142.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.57B | 1.55B | 1.50B | 1.54B | 1.50B |
| Operating Income | 340.80M | 470.30M | 328.30M | 402.10M | 392.50M |
| Income Before Tax | 229.10M | 289.10M | 230.40M | 302.20M | 215.10M |
| Income Tax Expenses | 46.50M | 48.90M | -18.90M | 59.10M | 42.30M |
| Earnings from Continuing Operations | 182.60M | 240.20M | 249.30M | 243.10M | 172.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -600.00K | -700.00K | -200.00K | -300.00K | -400.00K |
| Net Income | 182.00M | 239.50M | 249.10M | 242.80M | 172.40M |
| EBIT | 340.80M | 470.30M | 328.30M | 402.10M | 392.50M |
| EBITDA | 595.20M | 733.90M | 579.20M | 645.30M | 631.10M |
| EPS Basic | 0.92 | 1.20 | 1.23 | 1.18 | 0.84 |
| Normalized Basic EPS | 0.87 | 1.22 | 0.86 | 1.07 | 1.04 |
| EPS Diluted | 0.91 | 1.19 | 1.23 | 1.18 | 0.84 |
| Normalized Diluted EPS | 0.87 | 1.22 | 0.86 | 1.07 | 1.03 |
| Average Basic Shares Outstanding | 198.90M | 199.10M | 202.30M | 205.70M | 205.20M |
| Average Diluted Shares Outstanding | 199.70M | 199.90M | 203.00M | 206.40M | 206.20M |
| Dividend Per Share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 |
| Payout Ratio | 26.26% | 20.04% | 19.75% | 20.35% | 28.65% |